APPLICATIONS PUBLISHED 13 SEPTEMBER 2005
Compsn for treatment of ear disorders and methods for use thereof
Eilat, Eran 1699431*
Injectable phosphatidylcholine preparations
Aventis Pharmaceuticals 16994*
Oleaginous pharmaceutical and cosmetic foam
Foamix 1699433*
Process for preparing a medicament
Norton Health Care 1699434*
Particles
Norton Healthcare 1699435*
Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
Myogen; Aventis Pharmaceuticals 1699436*
Method for preparing solid dosage form of desmopressin
Ferring 1699437*
Pharmaceutical preparation containing gabapentin
Zambon Group 1699438*
Controlled-release pharmaceutical formulation
LEK Pharmaceuticals 1699439*
Method for the production of an administration form that is secured against misuse
Gruenenthal 1699440*
Fast-disintegrating tablets
Pantec 1699441*
Enteric coated aliphatic amine polymer bile acid sequestrants
Genzyme 1699442*
Pharmaceutical formulations of bisphosphonates
Novartis 1699443*
Means for inhibiting viral replication by regulation of protein folding
Viromics 1699444*
Collagen and polysaccharide-based coating compsn
FloEane Medical Implants 1699445*
Compsns and methods for treating hepatitis C virus infection
Rigel Pharmaceuticals 1699446*
Compsns comprising pantothenic acid or derivatives thereof and their use for stimulating appetite
NV Nutricia 1699447*
Methods of administering 3,3,14,14-tetramethyl hexadecane 1,16 dioic acid
Syndromex 1699448*
Use of a fatty acid compsn comprising at least one of EPA and DHA or any combinations thereof
Pronova Biocare 1699449*
Co-administration of dopamine-receptor binding compounds
Darpharma 1699450*
Use of at least one effector of glutathione metabolism, together with alpha-liponic acid for the treatment of lung diseases
Esparma; Imtm 1699451*
Use of statins for the treatment of metabolic syndrome
Novartis 1699452*
Cyclic guanidines, compsns containing such compounds and methods of use
Merck 1699453*
Pyrazole derivatives and use thereof as orexin receptor antagonists
Sanofi-Aventis 1699454*
Heterocyclic aspartyl protease inhibitors
Schering; Pharmacopoeia Drug Discovery 1699455*
Use of macrolides for treating or preventing airflow obstruction
Astellas Pharma 1699456*
Novel use of ion channel active compound, meperidine, to mediate process of accelerated wound healing
Nicel, Alfred 1699457*
Pharmaceutical compsn
Dr Reddy's Laboratories 1699458*
Method for treatment of multiple sclerosis
Can-Fite Biopharma 1699459*
Use of enzymatic inhibitors of H-prune for the prevention and treatment of the metastases of tumours overexpressing H-prune
Zollo, Massimo 1699460*
Treatment of hepatic fibrosis with imatinib mesylate
The Mount Sinai School of Medicine of New York University 1699461*
Reduction of toxicity of multi-targeting antifolates
Biofol 1699462*
Pharmaceutical compsn for treating and preventing cancer comprising Cinnamoni cortex extract and zizyphi fructus extract
Korea Research Institute of Bioscience and Biotechnology 1699463*
Menstrual cycle control and improvement of conception rates in females
Schering 1699464*
Treatment
University of Sheffield 1699465*
New compounds useful as metal chelators
Braco Imaging 1699466*
Aminoglyxoside antibiotics for use as VAP-1/SSAO inhibitors
Faron Pharmaceuticals 1699467*
Pharmaceutical compsn comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
Richter Gedeon Vegyeszeti Gyar 1699468*
Recombinant factor VII having increased specific activity
University of Rochester 1699469*
Biological active blood serum obtained by electrostimulation
Owen Holding 1699470*
Pharmaceutical active ingredient against hepatitis
Toximed 1699471*
Pharmaceutical active agent against breast cancer
Toximed 1699472*
Solvent for biogenic active pharmaceutical ingredients
Toximed 1699473*
Probiotic tablet formulation
Ferrosan 1699474*
An extract of the fruit of schisandra chinensis and its pharmaceutical and cosmetic use
Cognis France 1699475*
Method of preventing and treating diabetes using DG119
DeveloGen Aktiengesellschaft 1699476*
Compsns for use in the treatment of mutant tyrosine kinase driven cellular proliferative diseases
Theravance 1699477*
Treating inflammation using a biological agent that causes cells to release cytokine receptors
Meyer Pharmaceuticals 1699478*
Synthesis protein as tumour-specific vaccine
Leiden University Medical Centre 1699479*
Allogenic tumour therapeutic agent
Mologen 1699480*
Methods and compsns comprising bacteriophage nanoparticles
Rao, Venigalla Basaveswara 1699481*
Formulations of hydrophobic proteins in an immunogenic compsn having improved tolerability
Wyeth 1699482*